Paper
Document
Download
Flag content
0

A Phase 1 Study of the Oral CDK9 Inhibitor Voruciclib in Combination with Venetoclax in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

0
TipTip
Save
Document
Download
Flag content